Thrombosis in systemic lupus erythematosus: a review article
- PMID: 22900201
- PMCID: PMC3413961
- DOI: 10.5402/2012/428269
Thrombosis in systemic lupus erythematosus: a review article
Abstract
Thrombosis is a well-known clinical entity in systemic lupus erythematosus (SLE), and it is multifactorial. The most important risk factor is the presence of antiphospholipid antibodies (APLAs). However, approximately 40% of adults with SLE who are negative for APL A are diagnosed with thrombosis, indicating the importance of other risk factors. Thus, the thrombosis risk factors should be evaluated extensively and regularly and treated aggressively in every patient with systemic lupus erythematosus.
References
-
- Tassiulas IO, Boumpas DT. Clinical features and treatment of systemic lupus erythematosus. In: Firestein GS, Kelley WN, editors. Textbook of Rheumatology. 8th edition. Philadelphia, Pa, USA: Saunders/Elsevier; 2009.
-
- Ballou SP, Khan MA, Kushner I. Clinical features of systemic lupus erythematosus. Differences related to race and age of onset. Arthritis and Rheumatism. 1982;25(1):55–60. - PubMed
-
- Lawrence RC, Helmick CG, Arnett FC, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis and Rheumatism. 1998;41(5):778–799. - PubMed
-
- Al-Arfaj AS, Al-Balla SR, Al-Dalaan AN, et al. Prevalence of systemic lupus erythematosus in central Saudi Arabia. Saudi Medical Journal. 2002;23(1):87–89. - PubMed
-
- Afeltra A, Vadacca M, Conti L, et al. Thrombosis in systemic lupus erythematosus: congenital and acquired risk factors. Arthritis Care and Research. 2005;53(3):452–459. - PubMed
LinkOut - more resources
Full Text Sources
